Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2.
Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2.
复制标题
DOI:
10.1186/s13578-021-00723-0
复制
发表时间:
2021-12-08
影响因子:
7.5
通讯作者:
Liu J
中科院分区:
文献类型:
--
作者:
Cao H;Mai J;Zhou Z;Li Z;Duan R;Watt J;Chen Z;Bandara RA;Li M;Ahn SK;Poon B;Christie-Holmes N;Gray-Owen SD;Banerjee A;Mossman K;Kozak R;Mubareka S;Rini JM;Hu J;Liu J
The ongoing COVID-19 pandemic has resulted in 185 million recorded cases and over 4 million deaths worldwide. Several COVID-19 vaccines have been approved for emergency use in humans and are being used in many countries. However, all the approved vaccines are administered by intramuscular injection and this may not prevent upper airway infection or viral transmission. Here, we describe a novel, intranasally delivered COVID-19 vaccine based on a helper-dependent adenoviral (HD-Ad) vector. The vaccine (HD-Ad_RBD) produces a soluble secreted form of the receptor binding domain (RBD) of the SARS-CoV-2 spike protein and we show it induced robust mucosal and systemic immunity. Moreover, intranasal immunization of K18-hACE2 mice with HD-Ad_RBD using a prime-boost regimen, resulted in complete protection of the upper respiratory tract against SARS-CoV-2 infection. Our approaches provide a powerful platform for constructing highly effective vaccines targeting SARS-CoV-2 and its emerging variants. The online version contains supplementary material available at 10.1186/s13578-021-00723-0.
登录
查看更多内容
影响因子:
5.5
作者:
Guebre-Xabier M;Patel N;Tian JH;Zhou B;Maciejewski S;Lam K;Portnoff AD;Massare MJ;Frieman MB;Piedra PA;Ellingsworth L;Glenn G;Smith G
通讯作者:
Smith G
影响因子:
4.4
作者:
Christ, M;Lusky, M;Mehtali, M
通讯作者:
Mehtali, M
影响因子:
11.8
作者:
Banerjee, Arinjay;Nasir, Jalees A.;Mubareka, Samira
通讯作者:
Mubareka, Samira
影响因子:
4.2
作者:
Brunetti-Pierri, Nicola;Ng, Thomas;Ng, Philip
通讯作者:
Ng, Philip
影响因子:
5.1
作者:
Alba, R;Bosch, A;Chillon, M
通讯作者:
Chillon, M